atezolizumab
roche
['bladder', 'imvigor130', 'atezo']
imvigor130:chemo-\+ atezo no orr benefit with added atezo no median os difference but 8.5%diff at 36 months. #asco23 #bladdercancer 
On the road! Medical Oncologist & Prof @AnkaraUni | GU cancer expert  🔬| Diversity & Equity 📢 Advocate 💫  🌍 #Oncology #GenitourinaryCancer